go to contents

Pivaris BioScience GmbH

Back to list

Facts

Founded
2019
Staff
1
Organization type
RDM biotech/pharma
Region
Vienna
Focus
human health

Profile

Pivaris BioScience GmbH is a privately held Research

R&D:A novel, broad-acting antiviral peptide targeting double-stranded DNA viruses such as herpes simplex virus, cytomegalovirus, vaccinia virus, polyomavirus and adenoviruses has been identified. This first-in-class inhibitor is under evaluation for its use in the treatment of infections caused by double-stranded DNA viruses. The proprietary lead candidate of Pivaris BioScience GmbH is also being evaluated on various other virus models, including RNA viruses such as SARS-CoV-2.

Services:Pivaris BioScience GmbH offers consultancy for scientific projects in the area of biotechnology and can assist in solving technical and scientific problems. Pivaris BioScience GmbH also offers molecular and cell biology services - together with our partners, a wide range of applications can be covered, including cloning, PCR, cell-based assays, and biochemical assays.

Similar companies in RDM biotech/pharma

BDI - BioLife Science GmbH

Organization type
RDM biotech/pharma
Region
Styria
Cluster
Human.technology Styria
Focus
industrial processing
Details

Celgene GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

BlueSky Immunotherapies GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health / animal health
Details

Bender MedSystems GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
non-specific applications
Details

Contact

Media Quarter Marx 3.2, Maria-Jacobi-Gasse 1, 1. Stock
1030 Wien
Vienna

Contact: Hanna Harant (CEO)
Email: office@pivaris-bioscience.at
Website